Estimating the health state utility of patients with HER2-gBCRA+ metastatic breast cancer treated with olaparib or chemotherapy via a mapping analysis of EORTC QLQ-C30 data collected in the OlympiAD clinical trial Meeting Abstract


Authors: Robson, M.; Hettle, R.; Degboe, A.; Saunders, O.; Cain, T.; Kilvert, H.; Johnson, H.
Abstract Title: Estimating the health state utility of patients with HER2-gBCRA+ metastatic breast cancer treated with olaparib or chemotherapy via a mapping analysis of EORTC QLQ-C30 data collected in the OlympiAD clinical trial
Meeting Title: 23nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Journal Title: Value in Health
Volume: 21
Issue: Suppl. 1
Meeting Dates: 2018 May 19-23
Meeting Location: Baltimore, MD
ISSN: 1098-3015
Publisher: Elsevier Science, Inc.  
Date Published: 2018-05-01
Start Page: S12
Language: English
ACCESSION: WOS:000437739100058
DOI: 10.1016/j.jval.2018.04.058
PROVIDER: wos
Notes: Meeting Abstract: PP3 -- Source: Wos
Altmetric Score
MSK Authors
  1. Mark E Robson
    368 Robson